Equity

IOWAX

iShares Core S&P Small-Cap ETF Option

  • NAV as of Apr 15, 2025 $30.57
    52 WK: 28.78 - 40.02
  • 1 Day NAV Change as of Apr 15, 2025 -0.08 (-0.26%)
  • NAV Total Return as of Apr 15, 2025 YTD: -16.34%

Overview

Loading

Performance

Performance

  1y 3y 5y 10y
Total Return (%) -5.25 -0.25 12.52 5.69
Return w/ Sales Charge (%) -8.09 -1.26 11.84 5.37
Benchmark (%) -4.84 0.23 13.07 6.20
  YTD 1m 3m 1y 3y 5y 10y
Total Return (%) -9.06 -6.21 -9.06 -5.25 -0.75 80.40 73.98
Return w/ Sales Charge (%) -11.79 -9.02 -11.79 -8.09 -3.72 74.99 68.76
Benchmark (%) -8.93 -6.14 -8.93 -4.84 0.69 84.84 82.56
  2020 2021 2022 2023 2024
Total Return (%) 19.44 14.10 -20.77 16.37 9.34
Annual w/ Sales Charge (%) 13.17 8.11 -24.93 12.87 6.06
Benchmark (%) 19.96 14.82 -20.44 16.93 9.90

Performance is shown after deduction of ongoing charges. Any entry and exit charges are excluded from the calculation.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.
Click here for Distribution data

Key Facts

Key Facts

Size of Fund (Millions)
as of Apr 15, 2025
$56.1 M
Share Class launch date
Oct 08, 2010
Benchmark Index
S&P 600 Small Cap TR Index
CUSIP
19452W334
Open to New Investors
Yes
Size of Class (Millions)
as of Apr 15, 2025
$48.7 M
Asset Class
Equity
Distribution Frequency
None
Max Offer Price
as of Apr 15, 2025
$31.52
Expenses as of current program description

Portfolio Characteristics

Portfolio Characteristics

P/B Ratio
as of Mar 31, 2025
1.65
Alpha (3y)
as of Mar 31, 2024
0.00
R-Squared (3y)
as of Mar 31, 2024
0.00
Beta (3y)
as of Mar 31, 2024
0.00
P/E Ratio - Forward
as of Mar 31, 2025
0.00
Average Market Cap (Millions)
as of -
-
Fund Standard Deviation (3y)
as of Mar 31, 2024
0.00
Active Share
as of -
-
This information must be preceded or accompanied by a current program description. For standardized performance, please see the Performance section above.

Fees

Fees

as of current program description
Gross Expense Ratio 0.58%
Net Expense Ratio 0.58%

Net Expense Ratio excluding Investment Related Expenses is 0.39%

  • Acquired Fund Fees and Expenses 0.19%
  • Interest expense 0.00%

Holdings

Holdings

as of Mar 31, 2025
Name Weight (%)
CORCEPT THERAPEUTICS INCORPORATED 0.84
MR COOPER GROUP INC 0.60
QORVO INC 0.53
BRINKER INTERNATIONAL INC 0.52
TELEFLEX INCORPORATED 0.51
Name Weight (%)
TERRENO REALTY CORP 0.50
BORGWARNER INC 0.49
CELANESE CORPORATION 0.49
JACKSON FINANCIAL INC 0.49
MERIT MEDICAL SYSTEMS INC 0.49
Detailed Holdings and Analytics
The portfolio holds a mutual fund and/or an ETF. Top holdings from the underlying vehicles are listed above for greater visibility

Exposure Breakdowns

Exposure Breakdowns

as of Mar 31, 2025

% of Market Value

Show More
as of Mar 31, 2025

% of Market Value

Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

John Park
John Park
Portfolio Manager

Literature

Literature

No documents found